These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Persistent infection due to a small-colony variant of Burkholderia pseudomallei leads to PD-1 upregulation on circulating immune cells and mononuclear infiltration in viscera of experimental BALB/c mice. See JX; Chandramathi S; Abdulla MA; Vadivelu J; Shankar EM PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005702. PubMed ID: 28820897 [TBL] [Abstract][Full Text] [Related]
3. Experimental Persistent Infection of BALB/c Mice with Small-Colony Variants of Burkholderia pseudomallei Leads to Concurrent Upregulation of PD-1 on T Cells and Skewed Th1 and Th17 Responses. See JX; Samudi C; Saeidi A; Menon N; Choh LC; Vadivelu J; Shankar EM PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004503. PubMed ID: 26974441 [TBL] [Abstract][Full Text] [Related]
4. Development of protective immunity in a murine model of melioidosis is influenced by the source of Burkholderia pseudomallei antigens. Barnes JL; Ketheesan N Immunol Cell Biol; 2007 Oct; 85(7):551-7. PubMed ID: 17563759 [TBL] [Abstract][Full Text] [Related]
5. Programmed death ligand 1 on Burkholderia pseudomallei-infected human polymorphonuclear neutrophils impairs T cell functions. Buddhisa S; Rinchai D; Ato M; Bancroft GJ; Lertmemongkolchai G J Immunol; 2015 May; 194(9):4413-21. PubMed ID: 25801435 [TBL] [Abstract][Full Text] [Related]
6. Rapid identification of Burkholderia pseudomallei in blood cultures by a monoclonal antibody assay. Pongsunk S; Thirawattanasuk N; Piyasangthong N; Ekpo P J Clin Microbiol; 1999 Nov; 37(11):3662-7. PubMed ID: 10523570 [TBL] [Abstract][Full Text] [Related]
7. CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis. Musson JA; Reynolds CJ; Rinchai D; Nithichanon A; Khaenam P; Favry E; Spink N; Chu KK; De Soyza A; Bancroft GJ; Lertmemongkolchai G; Maillere B; Boyton RJ; Altmann DM; Robinson JH J Immunol; 2014 Dec; 193(12):6041-9. PubMed ID: 25392525 [TBL] [Abstract][Full Text] [Related]
10. Detection of virulence attributes of Burkholderia pseudomallei. Balaji V; Jesudason MV; Sridharan G; Subramanian K Indian J Med Res; 2004 Mar; 119(3):101-6. PubMed ID: 15115160 [TBL] [Abstract][Full Text] [Related]
11. In Vitro Priming of Human T Cells by Dendritic Cells Provides a Screening Tool for Candidate Vaccines for Reddi D; Durant L; Bernardo D; Noble A; English NR; Hendy P; Clark GC; Prior JL; Williamson ED; Knight SC Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452057 [TBL] [Abstract][Full Text] [Related]
12. Differential gene expression profiles of lung epithelial cells exposed to Burkholderia pseudomallei and Burkholderia thailandensis during the initial phase of infection. Wongprompitak P; Sirisinha S; Chaiyaroj SC Asian Pac J Allergy Immunol; 2009 Mar; 27(1):59-70. PubMed ID: 19548631 [TBL] [Abstract][Full Text] [Related]
13. Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells. Dando SJ; Ipe DS; Batzloff M; Sullivan MJ; Crossman DK; Crowley M; Strong E; Kyan S; Leclercq SY; Ekberg JAK; St John J; Beacham IR; Ulett GC Infect Immun; 2016 Jul; 84(7):1941-1956. PubMed ID: 27091931 [TBL] [Abstract][Full Text] [Related]
14. Adaptive immunity in melioidosis: a possible role for T cells in determining outcome of infection with Burkholderia pseudomallei. Barnes JL; Warner J; Melrose W; Durrheim D; Speare R; Reeder JC; Ketheesan N Clin Immunol; 2004 Oct; 113(1):22-8. PubMed ID: 15380526 [TBL] [Abstract][Full Text] [Related]
15. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. Healey GD; Elvin SJ; Morton M; Williamson ED Infect Immun; 2005 Sep; 73(9):5945-51. PubMed ID: 16113315 [TBL] [Abstract][Full Text] [Related]
16. Effects of Burkholderia pseudomallei and other Burkholderia species on eukaryotic cells in tissue culture. Harley VS; Dance DA; Drasar BS; Tovey G Microbios; 1998; 96(384):71-93. PubMed ID: 10093229 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of clinical Burkholderia pseudomallei isolates demonstrates conservation of unique lipid A structure and TLR4-dependent innate immune activation. Sengyee S; Yoon SH; Paksanont S; Yimthin T; Wuthiekanun V; Limmathurotsakul D; West TE; Ernst RK; Chantratita N PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006287. PubMed ID: 29474381 [TBL] [Abstract][Full Text] [Related]
18. Caspase-4 Mediates Restriction of Burkholderia pseudomallei in Human Alveolar Epithelial Cells. Srisaowakarn C; Pudla M; Ponpuak M; Utaisincharoen P Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31818963 [TBL] [Abstract][Full Text] [Related]
19. Atypical morphological characteristics and surface antigen expression of Burkholderia pseudomallei in naturally infected human synovial tissues. Nanagara R; Vipulakorn K; Suwannaroj S; Schumacher HR Mod Rheumatol; 2000 Sep; 10(3):129-36. PubMed ID: 24383589 [TBL] [Abstract][Full Text] [Related]
20. Comparative study of interleukin-1beta expression by peripheral blood mononuclear cells and purified monocytes experimentally infected with Burkholderia pseudomallei and Burkholderia thailandensis. Pongcharoen S; Niumsup PR; Butkhamchot P Immunol Invest; 2008; 37(7):704-13. PubMed ID: 18821217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]